Pharma emerging markets
1 June 2016 by
Pricing and cost-effectiveness and public hospital discussions from our trip to Asia
23 May 2016 by Cameron Lockwood
AA closer look at the access-to-medicines debate
22 March 2016 by Tania Rodrigues
A close look at the recent developments with DRGs
4 January 2016 by Jing Zhang
Understanding Chinese traditional medicine
21 December 2015 by Brendan Melck
How over the counter meds are changing the market landscape
16 November 2015 by Gustav Ando
A healthcare system in crisis, a pharmaceutical industry in decline, and acute shortages of essential medicines
9 September 2015 by Mark Hollis
Governments in the region are increasingly working together to harmonize regulatory approvals
8 July 2015 by Sophie Cairns
Thailand's battle against runaway pharmaceutical prices.
22 June 2015 by Kavita Rainova
A closer look at the Ukrainian healthcare system amidst the country's ongoing turmoil
2 June 2015 by Cameron Lockwood
The Middle East and North Africa is a region once again on the radar, following recent rumours that Valeant is considering a...
3 March 2015 by Milena Izmirlieva
Learn more about the trends in risk sharing agreements (known as patient access schemes (PAS) in some markets) and the...
27 February 2015 by Cecilia Chui
Economically, the Middle East (ME) is well positioned to be the one of next growth engine of global pharmaceutical sales:...
17 February 2015 by Angelica Kershaw
An improvement in relations offers the potential to open a new era in the Cuban pharma industry.
26 November 2014 by Kavita Rainova
The recent deal termination has refocused attention on the overall political, social and economic climate in Russia, as well...
About the Life Sciences BlogIndustry insights from the IHS Markit Life Sciences team covering market access, pricing and reimbursement, emerging markets, generics strategies, therapeutic development pathways, forecasting and market sizing, and general competitive intelligence. IHS Markit Blog Home »
Tweets by @IHS4LifeScience